Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344(19):1434-1441, 2001

William T. Couldwell  M.D. Ph.D.

首页> 外文期刊>Neurosurgical focus >Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344(19):1434-1441, 2001

【24h】

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344(19):1434-1441, 2001

机译：甲状旁腺激素（1-34）对绝经后骨质疏松妇女骨折和骨矿物质密度的影响。英格兰医学杂志344（19）：1434-1441，2001

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background Once-daily injections of parathyroid hormone or its amino-terminal fragments increase bone formation and bone mass without causing hypercalcemia, but their effects on fractures are unknown. Methods: We randomly assigned 1637 postmenopausal wome

机译：背景技术每天一次注射甲状旁腺激素或其氨基末端片段可增加骨形成和骨量，而不会引起高钙血症，但其对骨折的作用尚不清楚。方法：我们随机分配了1637个绝经后妇女

著录项

来源
《Neurosurgical focus》 |2001年第2期|共1页
作者
William T. Couldwell M.D. Ph.D.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类外科学;
关键词

相似文献

外文文献
中文文献
专利

1. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. [J] . Neer RM, Arnaud CD, Zanchetta JR, The New England journal of medicine . 2001,第19期

机译：甲状旁腺激素（1-34）对绝经后骨质疏松妇女骨折和骨矿物质密度的影响。
2. Erratum: A comparison of parathyroid hormone-related protein (1-36) and parathyroid hormone (1-34) on markers of bone turnover and bone density in postmenopausal women: The PrOP study (Journal of Bone and Mineral Research (2014) 29:3 (770) DOI: 10.1002/jbmr.2149)) [J] . HorwitzM.J., AugustineM., KhanL., Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research . 2014,第3期

机译：勘误：甲状旁腺激素相关蛋白（1-36）和甲状旁腺激素（1-34）在绝经后女性骨转换和骨密度标记中的比较：PrOP研究（《骨与矿物质研究》（2014）29： 3（770）DOI：10.1002 / jbmr.2149））
3. Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis. [J] . Lane NE, Sanchez S, Genant HK, Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA . 2000,第5期

机译：骨转换标志物的短期增加可预测患有糖皮质激素诱导的骨质疏松症的绝经后妇女的甲状旁腺激素诱导的脊髓骨矿物质密度增加。
4. Osteoporotic Fractures in Postmenopausal Women: Association with Age, Vertebral Pain Syndrome and Bone Mineral Density [C] . Povoroznyuk V., Orlyk T., Grygorieva N., World Congress of Pain Clinicians . 2012

机译：绝经后妇女骨质疏松骨折：与年龄，椎骨疼痛综合征和骨密度相关联
5. The relationship of vitamin D and selected nutrient intakes, sex hormone binding globulin and markers of bone turnover to bone mineral density in exercising and non-exercising postmenopausal women taking or not taking HRT. [D] . Sparks, Patricia Lynne. 2001

机译：在接受或不接受HRT的运动和非运动绝经后妇女中，维生素D与选定的营养摄入量，性激素结合球蛋白以及骨转换标志与骨矿物质密度的关系。
6. Single and Combined use of Human Parathyroid Hormone (PTH) (1-34) on Areal Bone Mineral Density (aBMD) in Postmenopausal Women with Osteoporosis: Evidence Based on 9 RCTs [O] . Jiefu Song, Zhizhen Jing, Feng Chang, 2014

机译：单独和联合使用人类甲状旁腺激素（PTH）（1-34）对绝经后骨质疏松症妇女的骨密度（aBMD）：基于9个RCT的证据
7. Single and Combined use of Human Parathyroid Hormone (PTH) (1-34) on Areal Bone Mineral Density (aBMD) in Postmenopausal Women with Osteoporosis: Evidence Based on 9 RCTs [O] . Yunxing Su 2014

机译：人甲状旁腺激素（PTH）（1-34）对骨质疏松症绝经妇女的面包骨矿物密度（ABMD）的单一和结合使用：基于9 RCT的证据

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344(19):1434-1441, 2001

摘要

著录项

相似文献

相关主题

期刊订阅